-
Window Dressing 06-30-2011
Thursday, June 30, 2011 - 2:41pm | 982Cusick's Corner The shopping continues today. Seems like the big money managers are continuing to improve their window, dressing up their end of the month to keep the statement in the green. This is money that is already in the market, but this recent move has scared the managers and hedge funds...
-
Thursday's Put/Call Ratio Leaders
Thursday, June 30, 2011 - 1:08pm | 77Here are today's Put/Call Ratio leaders… 1. Pharmacyclics Inc. (NASDAQ: PCYC) 5,548 puts, 4 calls 2. Meritor (NASDAQ: MTOR) 5,000 puts, 37 calls 3. EarthLink Inc. (NASDAQ: ELNK) 8,000 puts, 101 calls 4. EnerNOC Inc. (NASDAQ: ENOC) 2,864 puts, 53 calls 5. Crown Castle International (NYSE: CCI) 4,...
-
Prana: Quintiles Makes Second Investment in Prana of $1M
Thursday, June 30, 2011 - 10:34am | 68Prana Biotechnology Limited (NASDAQ: PRAN) announced today that leading global clinical research provider Quintiles will purchase shares in Prana for a total subscription of US$1,000,000. The funding will be used in support of Prana's recently announced business strategy to accelerate the clinical...
-
Morning Market Losers
Thursday, June 30, 2011 - 9:58am | 108Syntroleum Corporation (NASDAQ: SYNM) dipped 25.76% to $1.47 at 9:55 am. SYNM announced pricing of underwritten public offering of 15,900,000 shares of its common stock. Cell Therapeutics Inc (NASDAQ: CTIC) shares dropped 14.80% to $1.67. CTIC entered into an agreement to sell $30M of shares of...
-
Citi Discusses New Dendreon Plant
Thursday, June 30, 2011 - 9:27am | 101Citi Investment Research has a Hold rating and a $36 price target on shares of Dendreon (NASDAQ: DNDN). In the research note, Citi Investment Research writes, "Dendreon's LA manufacturing facility was approved. This facility houses 36 workstations and can generate between $375-$750M in sales. With...
-
Department of Defense Increases Development Contract With Cleveland BioLabs for CBLB502
Thursday, June 30, 2011 - 9:01am | 147Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it received a $1,531,034 increase (including option) in the development portion of the Company's existing contract, awarded on September 16, 2010, from the United States Department of Defense Chemical Biological and Medical Systems Medical...
-
Alkermes Announces Positive Results from Clinical Study of ALKS 9070
Thursday, June 30, 2011 - 8:01am | 124Alkermes, Inc. (NASDAQ: ALKS) today announced positive topline results from a phase 1b, double-blind, randomized, placebo-controlled study of ALKS 9070 in patients with schizophrenia. ALKS 9070, a proprietary Alkermes molecule for the treatment of schizophrenia, is designed to provide patients with...
-
Biggest Gainers and Losers in Pre-Market Trading
Thursday, June 30, 2011 - 7:58am | 249Gainers: US Airways (NYSE: LCC) is trading up near 12% after an agreement was announced yesterday with Greek airline Aegean. First Solar (NASDAQ: FSLR) is trading up near 6% after it was guaranteed 3 loans by the Department of Energy. Dendreon (NASDAQ: DNDN) is trading up near 2.50% after...
-
Aeterna Zentaris Announces "At-the-Market" Issuance Program to Sell up 9.5M Shares
Wednesday, June 29, 2011 - 4:17pm | 107Aeterna Zentaris Inc. (NASDAQ: AEZS) announced today that it has entered into an "At-the-Market" Sales Agreement, dated June 29, 2011, with McNicoll, Lewis & Vlak LLC, under which the Company may, at its discretion, from time to time during the 24-month term of the agreement, sell up to a...
-
Wednesday's Put/Call Ratio Leaders
Wednesday, June 29, 2011 - 1:54pm | 80Here are today's Put/Call Ratio leaders… 1. Ashford Hospitality Trust (NYSE: AHT) 5,000 puts, 33 calls 2. H&R Block Inc. (NYSE: HRB) 4,542 puts, 37 calls 3. Myriad Genetics (NASDAQ: MYGN) 3,038 puts, 28 calls 4. Ralcorp Holdings (NYSE: RAH) 3,083 puts, 62 calls 5. ResMed Inc. (NYSE: RMD) 6,034...
-
Options Brief: Myriad Genetics, Inc.
Wednesday, June 29, 2011 - 11:20am | 74Shares of Myriad Genetics, Inc. (NASDAQ: MYGN) are higher on the session by 0.35%, trading at $22.87. Overall put volume is now running at 4.82x the daily average, with 3% of all puts traded being purchases on the offer. 3,038 contracts have traded on the session so far. Myriad Genetics, Inc. is...
-
Goldman Sachs Reiterates Sell on Amgen
Wednesday, June 29, 2011 - 9:38am | 29Goldman Sachs reiterated its Sell rating on Amgen (NASDAQ: AMGN). In today's trading, Amgen lost 0.31% of its value to trade around $58.47.
-
Bank Of America Rates Human Genome Sciences Underperform
Wednesday, June 29, 2011 - 8:17am | 109According to Bank of America, Human Genome Sciences (NASDAQ: HGSI) is rated Underperform. Bank of America said that it found mixed results from our survey of 150 US physicians designed to assess initial market expectations for HGSI/GSK's recently launched lupus drug Benlysta. “Better than expected...
-
Alnylam Files Answer and Counterclaim Related to Tekmira Lawsuit
Wednesday, June 29, 2011 - 8:08am | 119Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) has filed an answer and counterclaim to an amended complaint filed by Tekmira Pharmaceuticals Corporation (Nasdaq: TKMR) in the Business Litigation Session of the Massachusetts Superior Court. Alnylam has also disclosed a research agreement and a related...
-
Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer
Wednesday, June 29, 2011 - 7:31am | 227Amicus Therapeutics (Nasdaq: FOLD) today announced that its Executive Chairman John F. Crowley will return full-time as Chairman and Chief Executive Officer, effective August 15, 2011, following his completion of temporary active duty with the United States Navy Reserve. Mr. Crowley previously led...